Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of ASU 2016-13, net of tax effect
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Adoption of ASU 2016-13, net of tax effect
Accumulated Other Comprehensive Income (Loss)
Non-controlling interests
Non-controlling interests
Adoption of ASU 2016-13, net of tax effect
Beginning Balance (in shares) at Dec. 31, 2019     66,338            
Beginning Balance at Dec. 31, 2019 $ 939,912 $ (14,105) $ 663 $ 1,102,303 $ (169,786) $ (14,031) $ 3,300 $ 3,432 $ (74)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 24,410       24,308     102  
Unrealized gain (loss) on available-for-sale securities 7,454           7,420 34  
Unrealized gain (loss) on interest rate swaps 358           356 2  
Issued shares of common stock (in shares)     4,506            
Issued shares of common stock 115,359   $ 45 115,314          
Equity-based compensation 5,520     4,581       939  
Issuance (repurchase) of vested equity-based compensation shares (in shares)     481            
Issuance (repurchase) of vested equity-based compensation shares (15,968)   $ 5 (15,973)          
Dividends and distributions (26,385)       (26,280)     (105)  
Ending Balance (in shares) at Mar. 31, 2020     71,325            
Ending Balance at Mar. 31, 2020 1,036,555   $ 713 1,206,225 (185,789)   11,076 4,330  
Beginning Balance (in shares) at Dec. 31, 2019     66,338            
Beginning Balance at Dec. 31, 2019 939,912 $ (14,105) $ 663 1,102,303 (169,786) $ (14,031) 3,300 3,432 $ (74)
Ending Balance (in shares) at Dec. 31, 2020     76,457            
Ending Balance at Dec. 31, 2020 1,210,149   $ 765 1,394,009 (204,112)   12,634 6,853  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 51,216       51,024     192  
Unrealized gain (loss) on available-for-sale securities (19,310)           (19,225) (85)  
Unrealized gain (loss) on interest rate swaps 1,240           1,232 8  
Issued shares of common stock (in shares)     1,639            
Issued shares of common stock 102,926   $ 16 102,910          
Equity-based compensation 4,678     2,639       2,039  
Issuance (repurchase) of vested equity-based compensation shares (in shares)     223            
Issuance (repurchase) of vested equity-based compensation shares (10,388)   $ 2 (10,390)          
Dividends and distributions (29,190)       (28,904)     (286)  
Ending Balance (in shares) at Mar. 31, 2021     78,319            
Ending Balance at Mar. 31, 2021 $ 1,311,321   $ 783 $ 1,489,168 $ (181,992)   $ (5,359) $ 8,721